AliveCor has launched the latest version of the AliveECG app, with two new Food and Drug Administration (FDA)-cleared and CE-marked automated detectors.
The new mobile app instantly detects when an ECG is either normal or unreadable. The normal detector allows patients to go about their regular daily activities knowing that no abnormalities were detected. The interference detector goes a step beyond the existing enhanced filter to make sure the ECG is readable and physicians receive only the highest quality recordings.
Now anytime an ECG is taken with the AliveCor Heart Monitor, the AliveECG app will tell users if atrial fibrillation is present, if the ECG is normal, or if there is too much interference and another ECG should be taken. All three detectors are available on iOS and Android in the USA, UK, Ireland, and India, and are free for a limited time.
“One of the most important things for our users is to provide them with confirmation that their ECG is normal, something typically only doctors could see. Our hard work on these automated detectors was validated when the FDA cleared this important diagnostic to be shared with consumers,” said Euan Thomson, president and chief executive officer at AliveCor. “When we introduced the AF Detector we saw a 50% increase in consumer recordings and expect similar results with our two new detectors.”